Saroja Pharma Industries India Balance Sheet Annual

BSE: - | NSE: - | ISIN: - | Sector: -

31.35 0.00 (0.00%)Updated : 06 Jul 2026

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Liabilities Shareholders' Equity	41.75	39.55	26.56	21.34
Cash Equivalents	0.34	0.33	0.32	0.36
Long Term Debt	7.36	1.38	2.62	2.81
Common Stock Total	4.02	4.02	4.02	2.94
Other Current Assets Total	0.03	0.16	0.59	0.77
Total Assets	41.75	39.55	26.56	21.34
Total Equity	17.29	15.68	14.64	5.09
Long Term Investments	0.54	0.34	0.20	0.14
Retained Earnings( Accumulated Deficit)	13.27	11.66	10.62	2.15
Total Common Shares Outstanding	0.40	0.40	0.40	0.40
Tangible Book Valueper Share Common Eq	43.00	38.99	36.42	12.65
Total Liabilities	24.46	23.88	11.92	16.25
Total Debt	14.41	9.46	5.74	10.19
Cashand Short Term Investments	0.34	0.33	0.32	0.36
Total Receivables Net	17.33	26.62	16.29	11.15
Notes Payable/ Short Term Debt	7.05	8.08	3.11	7.38
Deferred Income Tax	0.00	0.01	0.01	0.01
Accounts Receivable- Trade Net	17.30	26.58	16.24	11.11
Property/ Plant/ Equipment Total- Net	22.52	11.12	8.64	4.00
Total Current Liabilities	17.09	22.49	9.29	13.43
Total Inventory	0.86	0.10	0.40	3.87
Accounts Payable	8.47	13.65	5.61	5.86
Other Currentliabilities Total	1.57	0.77	0.57	0.19
Total Long Term Debt	7.36	1.38	2.62	2.81
Note Receivable- Long Term	0.13	0.88	0.13	1.04
Total Current Assets	18.56	27.22	17.60	16.15
period Length	0.00	0.00	0.00	0.00
Other Liabilities Total	-	0.00	-	-
Intangibles Net	-	-	0.00	0.00
Other Long Term Assets Total	-	-	-	0.00